The podocyte as a direct target for treatment of glomerular disease?

No abstract is available for this paper.

• Publication year

  2016

• Venue

  AJP - Renal Physiology

• Publication date

  2016-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1152/ajprenal.00184.2016PMID 27097894PMCID PMC4967158
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Melanocortin 1 receptor agonist protects podocytes through catalase and RhoA activation.

  2016cited by this paper
• The Beneficial Role of Retinoids in Glomerular Disease

  2015cited by this paper
• Co-stimulatory blockade with belatacept in kidney transplantation

  2014cited by this paper
• Effects of Melanocortin 1 Receptor Agonists in Experimental Nephropathies

  2014cited by this paper
• Unraveling the role of podocyte turnover in glomerular aging and injury.

  2014cited by this paper
• Leveraging melanocortin pathways to treat glomerular diseases.

  2014cited by this paper
• Abatacept in B7-1-positive proteinuric kidney disease.

  2013cited by this paper
• Treatment of idiopathic FSGS with adrenocorticotropic hormone gel.

  2013cited by this paper
• Podocyte repopulation by renal progenitor cells following glucocorticoids treatment in experimental FSGS.

  2013cited by this paper
• T-cell co-stimulatory blockade in transplantation: two steps forward one step back!

  2013cited by this paper
• Proteinuria impairs podocyte regeneration by sequestering retinoic acid.

  2013cited by this paper
• Krüppel-like Factor 15 (KLF15) Is a Key Regulator of Podocyte Differentiation*

  2012cited by this paper
• The renaissance of corticotropin therapy in proteinuric nephropathies

  2012cited by this paper
• Retinoids Augment the Expression of Podocyte Proteins by Glomerular Parietal Epithelial Cells in Experimental Glomerular Disease

  2012cited by this paper
• Clinical trial of focal segmental glomerulosclerosis in children and young adults.

  2011cited by this paper
• Focal segmental glomerulosclerosis.

  2011cited by this paper
• Novel Retinoic Acid Receptor Alpha Agonists for Treatment of Kidney Disease

  2011cited by this paper
• New therapies in steroid-sensitive and steroid-resistant idiopathic nephrotic syndrome

  2011cited by this paper
• Role of the retinoic acid receptor-α in HIV-associated nephropathy.

  2011cited by this paper
• Rituximab Targets Podocytes in Recurrent Focal Segmental Glomerulosclerosis

  2011cited by this paper
• The podocyte as a direct target of immunosuppressive agents.

  2011cited by this paper
• Roflumilast enhances the renal protective effects of retinoids in an HIV-1 transgenic mouse model of rapidly progressive renal failure

  2011cited by this paper
• Comparative effect of direct renin inhibition and AT1R blockade on glomerular filtration barrier injury in the transgenic Ren2 rat.

  2010cited by this paper
• Activation of NFAT signaling in podocytes causes glomerulosclerosis.

  2010cited by this paper
• Aliskiren inhibits intracellular angiotensin II levels without affecting (pro)renin receptor signals in human podocytes.

  2010cited by this paper
• Melanocortin 1 receptor agonists reduce proteinuria.

  2010cited by this paper
• Dose- and time-dependent glucocorticoid receptor signaling in podocytes.

  2010cited by this paper
• Mineralocorticoid receptor antagonism attenuates glomerular filtration barrier remodeling in the transgenic Ren2 rat.

  2009cited by this paper
• TRPC6 mutations associated with focal segmental glomerulosclerosis cause constitutive activation of NFAT-dependent transcription.

  2009cited by this paper
• Rituximab treatment of adult patients with steroid-resistant focal segmental glomerulosclerosis.

  2009cited by this paper
• The balance of autocrine VEGF-A and VEGF-C determines podocyte survival.

  2009cited by this paper
• Retinoic Acid Utilizes CREB and USF1 in a Transcriptional Feed-Forward Loop in Order To Stimulate MKP1 Expression in Human Immunodeficiency Virus-Infected Podocytes

  2008cited by this paper
• The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A

  2008cited by this paper
• Renin/prorenin receptor, (P)RR, in end-organ damage: current issues in 2007.

  2008cited by this paper
• Dexamethasone’s Prosurvival Benefits in Podocytes Require Extracellular Signal-Regulated Kinase Phosphorylation

  2008cited by this paper
• TRPC6 and FSGS: the latest TRP channelopathy.

  2007cited by this paper
• Retinoic acid inhibits HIV-1-induced podocyte proliferation through the cAMP pathway.

  2007cited by this paper
• Abatacept

  2006cited by this paper
• The effect of dexamethasone on defective nephrin transport caused by ER stress: a potential mechanism for the therapeutic action of glucocorticoids in the acquired glomerular diseases.

  2006cited by this paper
• Direct effects of dexamethasone on human podocytes.

  2006cited by this paper
• TRPC6 fulfills a calcineurin signaling circuit during pathologic cardiac remodeling.

  2006cited by this paper
• Vascular endothelial growth factor a signaling in the podocyte-endothelial compartment is required for mesangial cell migration and survival.

  2006cited by this paper
• Regression of existing glomerulosclerosis by inhibition of aldosterone.

  2005cited by this paper
• ATRA induces podocyte differentiation and alters nephrin and podocin expression in vitro and in vivo.

  2005cited by this paper
• Aldosterone and end-organ damage

  2005cited by this paper
• Differential proteomic analysis of proteins induced by glucocorticoids in cultured murine podocytes.

  2005cited by this paper
• Dexamethasone prevents podocyte apoptosis induced by puromycin aminonucleoside: role of p53 and Bcl-2-related family proteins.

  2005cited by this paper
• Aldosterone and end-organ damage.

  2005cited by this paper
• Impact of Cyclosporin on Podocyte ZO-1 Expression in Puromycin Aminonucleoside Nephrosis Rats

  2005cited by this paper
• Activation of a local tissue angiotensin system in podocytes by mechanical strain.

  2004cited by this paper
• Calcineurin: a central controller of signalling in eukaryotes

  2004cited by this paper
• Induction of B7-1 in podocytes is associated with nephrotic syndrome.

  2004cited by this paper
• Angiotensin II type 1 receptor overexpression in podocytes induces glomerulosclerosis in transgenic rats.

  2004cited by this paper
• Association of Immunophilins with Mammalian TRPC Channels*

  2004cited by this paper
• Molecular mechanisms of immunomodulatory activity of glucocorticoids.

  2002cited by this paper
• Retinoid receptor-specific agonists alleviate experimental glomerulonephritis.

  2002cited by this paper
• Hepatocyte growth factor, but not insulin-like growth factor I, protects podocytes against cyclosporin A-induced apoptosis.

  2001cited by this paper
• Vascular endothelial growth factor mRNA expression in minimal change, membranous, and diabetic nephropathy demonstrated by non-isotopic in situ hybridisation.

  1999cited by this paper
• Subcellular localization of glucocorticoid receptor protein in the human kidney glomerulus.

  1999cited by this paper
• Anti-inflammatory actions of glucocorticoids: molecular mechanisms.

  1998cited by this paper
• Retinoids.

  1997cited by this paper
• Expression of vascular endothelial growth factor and its receptors in human renal ontogenesis and in adult kidney.

  1995cited by this paper
• The Retinoids

  1987cited by this paper
• Effect of ACTH in children with the nephrotic syndrome.

  1952cited by this paper
• Effect of corticotropin (ACTH) on children with the nephrotic syndrome.

  1951cited by this paper

• Podocytes in health and disease: from development to regeneration

  2025cites this paper
• Cobalt Protoporphyrin IX Attenuates Antibody-Mediated, Complement-Dependent Podocyte Injury: Role of Cobalt and Porphyrin Moieties

  2025cites this paper
• AMPK Activation by 2′‐Hydroxy‐2,4,5‐Trimethoxychalcone Derivatives in Podocyte Cells

  2025cites this paper
• Association between lactate dehydrogenase to albumin ratio and ICU mortality in patients with acute kidney injury: a retrospective cohort study

  2025cites this paper
• Autophagy inhibitor 3-methyladenine attenuates renal injury in streptozotocin-induced diabetic mice

  2024cites this paper
• Podocyte-related biomarkers' role in evaluating renal toxic effects of silver nanoparticles with the possible ameliorative role of resveratrol in adult male albino rats

  2024cites this paper
• Detailed Pathophysiology of Minimal Change Disease: Insights into Podocyte Dysfunction, Immune Dysregulation, and Genetic Susceptibility

  2024influential citation
• RNA-Seq-Based Transcriptome Analysis of Chinese Cordyceps Aqueous Extracts Protective Effect against Adriamycin-Induced mpc5 Cell Injury

  2024cites this paper
• Blood pressure management strategies and podocyte health.

  2024cites this paper
• A Small Molecule Agonist of Krüppel-Like Factor 15 in Proteinuric Kidney Disease

  2024cites this paper
• The elevated lactate dehydrogenase to albumin ratio is a risk factor for developing sepsis-associated acute kidney injury: a single-center retrospective study

  2024cites this paper
• PIK3CA inhibition in models of proliferative glomerulonephritis and lupus nephritis

  2024cites this paper
• Research advances of mitochondrial autophagy in renal diseases

  2023cites this paper
• Curcumin ameliorates focal segmental glomerulosclerosis by inhibiting apoptosis and oxidative stress in podocytes.

  2023cites this paper
• A sulfonamide chalcone AMPK activator ameliorates hyperglycemia and diabetic nephropathy in db/db mice.

  2023cites this paper
• Synthesis and biological evaluation of 2'-hydroxychalcone derivatives as AMPK activators.

  2023cites this paper
• Bioenergetics: The Evolutionary Basis of Progressive Kidney Disease.

  2023cites this paper
• Piceatannol-3'-O-β-d-glucopyranoside alleviates nephropathy via regulation of High mobility group B-1 (HMGB1)/Toll-like receptor 4 (TLR4)/Nuclear factor kappa B (NF-κB) signalling pathway.

  2023cites this paper
• tRNA-Derived Small RNAs: A Novel Regulatory Small Noncoding RNA in Renal Diseases

  2023cites this paper
• Icariin synergizes therapeutic effect of dexamethasone on adriamycin-induced nephrotic syndrome

  2023cites this paper
• miRNA-93-5p in exosomes derived from M2 macrophages improves lipopolysaccharide-induced podocyte apoptosis by targeting Toll-like receptor 4

  2022cites this paper
• Glucocorticoids Inhibit EGFR Signaling Activation in Podocytes in Anti-GBM Crescentic Glomerulonephritis

  2022cites this paper
• Cynapanoside A exerts protective effects against obesity-induced diabetic nephropathy through ameliorating TRIM31-mediated inflammation, lipid synthesis and fibrosis.

  2022cites this paper
• Modeling of ACTN4-Based Podocytopathy Using Drosophila Nephrocytes

  2022cites this paper
• Role of Nanotechnology and Their Perspectives in the Treatment of Kidney Diseases

  2022cites this paper
• Polydatin Ameliorates High Fructose-Induced Podocyte Oxidative Stress via Suppressing HIF-1α/NOX4 Pathway

  2022cites this paper
• Mechanisms of Scarring in Focal Segmental Glomerulosclerosis

  2021cites this paper
• Chinese Herbal Medicine and Targeted Delivery Strategy for the Treatment of Kidney Disease

  2021cites this paper
• Mitochondria Damage and Kidney Disease

  2021cites this paper
• Glucocorticoid receptor wields chromatin interactions to tune transcription for cytoskeleton stabilization in podocytes

  2021cites this paper
• New indication of Chuankezhi injection for steroid-resistant focal segmental glomerulosclerosis and its mechanism of action

  2021cites this paper
• Glucocorticoid receptor wields chromatin interactions to tune transcription for cytoskeleton stabilization in podocytes

  2021cites this paper
• Transforming growth factor-β1-induced podocyte injury is associated with increased microRNA-155 expression, enhanced inflammatory responses and MAPK pathway activation

  2021cites this paper
• General Sites of Nanoparticle Biodistribution As a Novel Opportunity for Nanomedicine.

  2021cites this paper
• Losartan Protects Podocytes against High Glucose-induced Injury by Inhibiting B7-1 Expression

  2021cites this paper
• Renal Cell-Targeted Drug Delivery Strategy Based on Acute Kidney Injury and Chronic Kidney Disease: A Mini-Review.

  2021cites this paper
• PP2A protects podocytes against Adriamycin-induced injury and epithelial-to-mesenchymal transition via suppressing JIP4/p38-MAPK pathway

  2021cites this paper
• Voclosporin: a novel calcineurin inhibitor for the management of lupus nephritis

  2021cites this paper
• A girl with a mutation of the ciliary gene CC2D2A presenting with FSGS and nephronophthisis

  2021cites this paper
• The Lupus Nephritis Management Renaissance.

  2021cites this paper
• Urinary expression of long non-coding RNA TUG1 in non-diabetic patients with glomerulonephritides.

  2020cites this paper
• The impact of steroids on the injured podocytes in nephrotic syndrome.

  2020cites this paper
• Quercetin liposomes ameliorate streptozotocin-induced diabetic nephropathy in diabetic rats

  2020cites this paper
• Defective Mitochondrial Fatty Acid Oxidation and Lipotoxicity in Kidney Diseases

  2020cites this paper
• Myo-inositol Oxygenase (MIOX) Overexpression Drives the Progression of Renal Tubulointerstitial Injury in Diabetes

  2020cites this paper
• The Krüppel-Like Factor 15-NFATc1 Axis Ameliorates Podocyte Injury: A Novel Rationale for Using Glucocorticoids in Proteinuria Diseases.

  2020cites this paper
• Crk1/2 and CrkL play critical roles in maintaining podocyte morphology and function.

  2020cites this paper
• Physiology and Pathophysiology of Compensatory Adaptations of a Solitary Functioning Kidney

  2020cites this paper
• Phosphorylation of key podocyte proteins and the association with proteinuric kidney disease.

  2020cites this paper
• Advances in kidney-targeted drug delivery systems.

  2020cites this paper
• Ginsenoside Rg1 Alleviates Podocyte Injury Induced by Hyperlipidemia via Targeting the mTOR/NF-κB/NLRP3 Axis

  2020cites this paper
• Intracellular complement activation in podocytes aggravates immune kidney injury in trichloroethylene-sensitized mice.

  2020cites this paper
• Reduced Lon protease 1 expression in podocytes contributes to the pathogenesis of podocytopathy.

  2020cites this paper
• Posttranslational Modifications Pattern in Clear Cell Renal Cell Carcinoma

  2020cites this paper
• Astragaloside IV inhibits glucose-induced epithelial-mesenchymal transition of podocytes through autophagy enhancement via the SIRT–NF-κB p65 axis

  2019cites this paper
• Successful Treatment of Focal Segmental Glomerulosclerosis Recurrence in a Second Kidney Transplant Patient: A Case Report.

  2019cites this paper
• DMSO_A_217924 1811..1820

  2019cites this paper
• Fractalkine is Involved in Lipopolysaccharide-Induced Podocyte Injury through the Wnt/β-Catenin Pathway in an Acute Kidney Injury Mouse Model

  2019cites this paper
• Calpain-10 drives podocyte apoptosis and renal injury in diabetic nephropathy

  2019cites this paper
• Adrenocorticotropic Hormone in the Treatment of Focal Segmental Glomerulosclerosis Following Kidney Transplantation.

  2019cites this paper
• Therapeutic and antiproteinuric effects of salvianolic acid A in combined with low-dose prednisone in minimal change disease rats: Involvement of PPARγ/Angptl4 and Nrf2/HO-1 pathways.

  2019cites this paper
• Targeting strategies for drug delivery to the kidney: From renal glomeruli to tubules

  2018cites this paper
• Understanding Podocyte Biology to Develop Novel Kidney Therapeutics

  2018cites this paper
• Emodin mitigates podocytes apoptosis induced by endoplasmic reticulum stress through the inhibition of the PERK pathway in diabetic nephropathy

  2018cites this paper
• Protective role of Trpc6 knockout in the progression of diabetic kidney disease.

  2018cites this paper
• Renoprotective effects of ET(A) receptor antagonists therapy in experimental non-diabetic chronic kidney disease: Is there still hope for the future?

  2018cites this paper
• FPS-ZM1 and valsartan combination protects better against glomerular filtration barrier damage in streptozotocin-induced diabetic rats

  2018cites this paper
• Tripterygium glycoside protects against puromycin amino nucleoside-induced podocyte injury by upregulating autophagy

  2018cites this paper
• Partial Remission of Proteinuria as a Prognostic Indicator of the Outcome of the Focal Segmental Glomerulosclerosis in Children and Young Adults with Nephrotic Syndrome

  2018cites this paper
• Trans‐resveratrol mitigates type 1 diabetes‐induced oxidative DNA damage and accumulation of advanced glycation end products in glomeruli and tubules of rat kidneys

  2018cites this paper
• The role of podocytes dysfunction in chronic glomerulonephritis progression.

  2018cites this paper
• Differentiation of human iPSCs into functional podocytes

  2018cites this paper
• Focal Segmental Glomerulosclerosis.

  2017cites this paper
• H 2 O 2 induces caveolin ‐ 1 degradation and impaired mitochondrial function in E 11 podocytes

  2017cites this paper
• Wenyang Huoxue Lishui formula ameliorates doxorubicin-induced nephrotic syndrome in a rat model by reducing cathepsin L expression

  2017cites this paper
• [Research advances in the protective effect of all-trans retinoic acid against podocyte injury].

  2017cites this paper
• Podocytes from the diagnostic and therapeutic point of view

  2017cites this paper
• Mitochondria Damage and Kidney Disease.

  2017cites this paper
• H2O2 induces caveolin‑1 degradation and impaired mitochondrial function in E11 podocytes.

  2017cites this paper
• Exosomes from high glucose-treated glomerular endothelial cells trigger the epithelial-mesenchymal transition and dysfunction of podocytes

  2017cites this paper
• Nanomedicines for renal disease: current status and future applications

  2016cites this paper
• Rôle de l'épithélium et de l'endothélium rénal au cours des glomérulopathies expérimentales. Etude des glomérulonéphrites inflammatoires et des glomérulopathies toxique et hypertensive

  2016cites this paper
• Correlation study of podocyte injury and kidney function in patients with acute kidney injury

  2016cites this paper